Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/25200
Title: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Authors: 
Mesh: 
Issue Date: Oct-2016
Citation: Am. J. Gastroenterol..2016 Oct;(111)10:1456-1465
Abstract: Treatment for celiac disease (CD) is a lifelong strict gluten-free diet (GFD). Patients should be followed-up with dietary interviews and serology as CD markers to ensure adherence to the diet. However, none of these methods offer an accurate measure of dietary compliance. Our aim was to evaluate the measurement of gluten immunogenic peptides (GIP) in stools as a marker of GFD adherence in CD patients and compare it with traditional methods of GFD monitoring.
PMID: 27644734
URI: https://hdl.handle.net/20.500.12530/25200
Rights: openAccess
Appears in Collections:Hospitales > H. U. Tajo > Artículos

Files in This Item:
File Description SizeFormat 
PMC5059698.pdf373.82 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.